The company confirmed this morning that NICE has taken the "unusual decision" to hold a third appraisal committee meeting as part of its ongoing evaluation of Leqembi (lecanemab), which was turned ...

Music can have profound benefits for humans. It can promote healing, ease pain, treat anxiety and depression, and help us ...

NPR's Jon Hamilton has been talking to people who've taken these drugs, and today he has the story of one of the first patients to receive the drug now marketed as Leqembi. JON HAMILTON ...

The milestone was reached as sales of Leqembi reached €200 million in Eisai fiscal year 2024 (April 2024 - Match 2025). The event entitles BioArctic to a €10 million payment. Leqembi is the ...

Elvis, who was strongly influenced by and nurtured on Black music, was a part of the revolution that stood up against Jim ...

Share on Facebook Share on Twitter Kenny Chesney will release his first book, Heart Life Music, on Nov. 4, 2025 (via William ...

his music; and sections on his record label, his remixes, his many aliases, and his collaborators and devotees. At the intersection of history and fandom, the book demonstrates how the ephemeral ...

For Eisai and Biogen, the CHMP’s decision to stick by its previous call now punts the final approval verdict for Leqembi back to the European Commission (EC), which is the ultimate authority on ...

St. Charles, Missouri, resident Sue Bell became one of the first Alzheimer's patients in the U.S. to receive the drug now marketed as Leqembi. Her husband isn't sure if it made a difference.

Two widely touted Alzheimer’s drugs have been shown to enable patients to remain in their homes, living independently, for longer periods of time. Those medications, while effective, are not ...

In 2020, Sue Bell became one of the first Alzheimer's patients in the U.S. to receive the drug now marketed as Leqembi. Four years later, she and her husband, Ken, halted the treatment.